dean22029/WTO_Docs huggingface dataset:
EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from Argentina
Date: 11 June 2003
Document codes: WT/DS292/5
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from Argentina
The following communication, dated 30 May 2003, from the Permanent Mission of Argentina
to the Permanent Delegation of the European Commission, the Permanent Mission of Canada and the
Chairman of the Dispute Settlement Body is circulated in accordance with Article 4.11 of the Dispute
Settlement Understanding (DSU).
Pursuant to Article 4.11 of the Understanding on Rules and Procedures Governing the
Settlement of Disputes (DSU), I hereby notify you of the desire of the Government of the Argentine
Republic to be joined in the consultations requested by the United States and Canada under Article 4
of the DSU, Article 11 of the Agreement on the Application of Sanitary and Phytosanitary Measures
(SPS Agreement), Article 19 of the Agreement on Agriculture, Article 14 of the Agreement on
Technical Barriers to Trade (TBT Agreement) and Article XXII of the General Agreement on Tariffs
and Trade 1994 (GATT 1994) with regard to certain measures taken by the European Communities
and its Member States affecting products of biot echnology (biotech products). The Communications
from the Permanent Mission of the United States and the Permanent Mission of Canada to the
Permanent Delegation of the European Commission, both dated 13 May 2003, were circulated to
WTO Members on 20 May 2003 ( and respectively).
The Argentine Republic, as a global producer and exporter of biotechnology products, has a
systemic and substantial trade interest in these consultations and has requested its own consultations
on this issue ().
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from Brazil
Date: 12 June 2003
Document codes: WT/DS292/6
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from Brazil
The following communication, dated 28 May 2003, from the Permanent Mission of Brazil to
the Permanent Delegation of the European Commission, the Permanent Mission of Canada and to the
Chairman of the Dispute Settlement Body, is circulated in accordance with Article 4.11 of the DSU.
I refer to the requests for consultations by the United States, Canada, and Argentina with
regard to certain measures taken by the European Communities and its member States affecting
products of biotechnology (biotech products), made on 13 and 14 May 2003, pursuant to Article 4 of
the Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU), Article 11
of the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement),
Article 19 of the Agreement on Agriculture , Article 14 of the Agreement on Technical Barriers to
Trade (TBT Agreement) and Article XXII of the General Agreement on Tariffs and Trade 1994
(GATT 1994), which were circulated to Members on 20 and 21 May 2003 (respectively,
, , EN/397, , 28; , ,
, , ; and , , ,

Brazil has substantial trade interests in the matter, as one of the largest world exporters of
agricultural commodities and one of the countries of greatest biodiversity in the world, among other
reasons. I therefore wish to convey the desire of the Government of Brazil, pursuant to Article 4.11 of
the DSU, to join in those consultations.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from India
Date: 12 June 2003
Document codes: WT/DS292/7
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from India
The following communication, dated 4 June 2003, from the Permanent Mission of India to the
Permanent Delegation of the European Commission, the Permanent Mission of Canada and to the
Chairman of the Dispute Settlement Body, is circulated in accordance with Article 4.11 of the DSU.
Pursuant to Article 4.11 of the Understanding on Rules and Procedures Governing the
Settlement of Disputes (DSU), the Government of Indi a hereby notifies its desire to be joined in the
consultations requested by the Permanent Mission of Canada to the Permanent Delegation of the
European Communities and to the Chairman of the Dispute Settlement Body (DSB) pursuant to
Article 4 of the Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU),
Article XXII of the General Agreement on Tariffs and Trade 1994 (GATT 1994), Article 11 of the
Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement), Article 19
of the Agreement on Agriculture, and Article 14 of the Agreement on Technical Barriers to Trade
(TBT Agreement), concerning measures affecting the approval and marketing of products that
contain, consist of, or are produced from, genetic ally modified organisms (GM products). The
13 May 2003 communication from the Permanent Mission of Canada to the Permanent Delegation of
the European Commission was circulated to WTO members on 20 May 2003 (, ,

India has a systemic interest in the consultations on the matter in the dispute. We would be
grateful for being informed of the date and venue of consultations, so as to enable us to participate in
the consultations.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from New Zealand
Date: 12 June 2003
Document codes: WT/DS292/8
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from New Zealand
The following communication, dated 28 May 2003, from the Permanent Mission of
New Zealand to the Permanent Delegation of the European Commission, the Permanent Mission of
Canada and to the Chairman of the Dispute Settlement Body, is circulated in accordance with
Article 4.11 of the DSU.
Pursuant to paragraph 11 of Article 4 of the Understanding on Rules and Procedures
Governing the Settlement of Disputes (DSU), th e Government of New Zealand hereby notifies the
European Communities and the Dispute Settlement Body that New Zealand desires to be joined in the
consultations requested by the United States, Canada, and Argentina pursuant to Article 4 of the DSU,
Article XXII of the General Agreement on Tariffs and Trade 1994, Article 11 of the Agreement on
the Application of Sanitary and Phytosanitary Measures, Article 19 of the Agreement on Agriculture
and Article 14 of the Agreement on Technical Barriers to Trade, concerning certain measures taken
by the European Communities and its Member States affecting biotechnology products. The requests
for consultations on this matter have been circulated in WTO documents , ,
and
We look forward to the European Communities' confirmation of receipt and acceptance of
this request to join the consultations and advice regarding the timing and venue for the consultations.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Acceptance by the European Communities of the Requests to Join Consultations Australia, Argentina, Brazil, India, Mexico, New Zealand and the United States notified the Dispute Settlement Body (DSB) of their desire to be joined in the consultations requested by the United States, pursuant to Article 4.11 of the DSU. The Permanent Delegation of the European Commission informed the DSB that it had accepted the requests of Australia, Argentina, Brazil, India, Mexico, New Zealand and the United States to join the consultations. COMMUNAUTÉS EUROPÉENNES – MESURES AFFECTANT L'APPROBATION ET LA COMMERCIALISATION DES PRODUITS BIOTECHNOLOGIQUES Acceptation par les Communautés européennes des demandes de participation aux consultations L'Argentine, l'Australie, le Brésil, les États-Unis, l'Inde, le Mexique et la Nouvelle-Zélande ont fait savoir à l'Organe de règlement des différends (ORD) qu'ils désiraient être admis à participer aux consultations demandées par le Canada, conformément à l'article 4:11 du Mémorandum d'accord sur le règlement des différends.
Date: 19 June 2003
Document codes: WT/DS292/16
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Acceptance by the European Communities of the Requests to Join Consultations
Australia, Argentina, Brazil, India, Mexico, New Zealand and the United States notified the
Dispute Settlement Body (DSB) of their desire to be joined in the consultations requested by the
United States, pursuant to Article 4.11 of the DSU.
The Permanent Delegation of the European Commission informed the DSB that it had
accepted the requests of Australia, Argentina, Brazil, India, Mexico, New Zealand and the
United States to join the consultations.
COMMUNAUTÉS EUROPÉENNES – MESURES AFFECTANT L'APPROBATION
ont fait savoir à l'Organe de règlement des différends (ORD) qu'ils désiraient être admis à participer
COMERCIALIZACIÓN DE PRODUCTOS BIOTECNOLÓGICOS
Estados Unidos, la India, México y Nueva Zelandia.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Acceptance by the European Communities of the Requests to Join Consultations Corrigendum Paragraph 1, 3rd line, replace "the United States" by "Canada".
Date: 13 August 2003
Document codes: WT/DS292/16/Corr.11
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Acceptance by the European Communities of the Requests to Join Consultations
Corrigendum
Paragraph 1, 3rd line, replace "the United States" by "Canada".
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Agreement under Article 21.3(b) of the DSU
Date: 26 June 2007
Document codes: WT/DS292/29
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Agreement under Article 21.3(b) of the DSU

 The following communication, dated 21 June 2007, from the delegati on of Canada and the
delegation of the European Communities to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 Pursuant to Article 21.3(b) of the Understanding on Rules and Procedures Governing the
Settlement of Disputes, Canada and the European Communities have agreed that the reasonable period
of time for the European Communities to implemen t the recommendations and rulings of the Dispute
Settlement Body in the above-referenced dispute sh all be twelve (12) months from the date of
adoption of the panel report, 21 November 2006. A ccordingly, the reasonable period of time expires
on 21 November 2007. We request that you circulate this notification to the Members of the Dispute
Settlement Body.

For Canada:

(signed)
H.E. Don Stephenson
Ambassador
For the European Communities:

(signed)
H.E. Mr. Eckart Guth
Ambassador
EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 23 November 2007
Document codes: WT/DS292/30
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 21 November 2007, from the delegation of the
European Communities and the delegation of Canada to the Chairman of the Dispute Settlement
Body, is circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute European Communities – Measures Affecting the Approval and
Marketing of Biotech Products (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to modify the "reasonable period of time" for
implementation of the recommendations and rulings of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 21 November 2007. The reasonable
period of time in this dispute will now expire on 11 January 2008. We request that you circulate this
notification to the Members of the Dispute Settlement Body.

For the European Communities

For Canada

H.E. Eckart Guth
Ambassador

H.E. Don Stephenson
Ambassador
EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 16 January 2008
Document codes: WT/DS292/32
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 11 January 2008, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute European Communities – Measures affecting the Approval and
Marketing of Biotech Products (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3 (b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 11 January 2008. The reasonable period
of time in this dispute will now expire on 11 February 2008.

 We request that you circulate this notifica tion to the Members of the Dispute Settlement
Body.

For the European Communities

For Canada

H.E. Eckart Guth
Ambassador

H.E. Don Stephenson
Ambassador
EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 13 February 2008
Document codes: WT/DS292/33
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 11 February 2008, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute European Communities – Measures Affecting the Approval and
Marketing of Biotech Products (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 11 Februa ry 2008. The reasonable period
of time in this dispute will now expire on 30 June 2008. We request that you circulate this notification
to the Members of the Dispute Settlement Body.

For the European Communities

For Canada

H.E. Eckart Guth
Ambassador

H.E. Don Stephenson
Ambassador
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 24 June 2008
Document codes: WT/DS292/34
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 23 June 2008, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 30 June 2008. The reasonable period of
time in this dispute will now expire on 31 July 2008. We request that you circulate this notification to
the Members of the Dispute Settlement Body.

For the European Communities

For Canada
H.E. Eckart Guth
Ambassador
H.E. Don Stephenson
Ambassador
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 30 July 2008
Document codes: WT/DS292/35
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 29 July 2008, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 31 July 2008. The reasonable period of
time in this dispute will now expire on 31 Dece mber 2008. We request that you circulate this
notification to the Members of the Dispute Settlement Body.

For the European Communities

For Canada
H.E. Eckart Guth
Ambassador
H.E. Don Stephenson
Ambassador
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 19 December 2008
Document codes: WT/DS292/36
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 16 Decembe r 2008, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 31 December 2008. The reasonable period
of time in this dispute will now expire on 1 Ma rch 2009. We request that you circulate this
notification to the Members of the Dispute Settlement Body.

For the European Communities

H.E. Mr. Eckart Guth
Ambassador
For Canada

H.E. Mr. John Gero
Ambassador
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 27 February 2009
Document codes: WT/DS292/37
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 25 February 2009, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 1 March 2009. The reasonable period of
time in this dispute will now expire on 1 May 2009. We request that you circulate this notification to
the Members of the Dispute Settlement Body.

For the European Communities

H.E. Mr. Eckart Guth
Ambassador
Permanent Representative
for the European Communities
For Canada

Ms. Heather Grant
Deputy Permanent Representative
for Canada
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 29 April 2009
Document codes: WT/DS292/38
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 27 April 2009, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 2 1.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 1 May 2009. The reasonable period of
time in this dispute will now expire on 30 June 2009. We request that you circulate this notification
to the Members of the Dispute Settlement Body.

For the European Communities

H.E. Mr. Eckart Guth
Ambassador
Permanent Representative
of the European Communities
For Canada

Ms. Heather Grant
Minister
Deputy Permanent Representative
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU
Date: 2 July 2009
Document codes: WT/DS292/39
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

 The following communication, dated 30 June 2009, from the delegation of the European
Communities and the delegation of Canada to the Chairman of the Dispute Settlement Body, is
circulated in accordance with Article 21.3(b) of the DSU.

 With regard to the dispute (WT/DS292), we are pleased to inform you that the European
Communities and Canada have mutually agreed to m odify once more the "reasonable period of time"
for implementation of the recommendations and ruli ngs of the Dispute Settlement Body, which was
originally established pursuant to Article 21.3(b) of the Understanding on Rules and Procedures
Governing the Settlement of Disputes and was to expire on 30 June 2009. The reasonable period of
time in this dispute will now expire on 31 Decem ber 2009. We request that you circulate this
notification to the Members of the Dispute Settlement Body.

For the European Communities

H.E. Mr. Eckart Guth
Ambassador
Permanent Representative
of the European Communities
For Canada

Ms. Heather Grant
Minister
Deputy Permanent Representative
EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Modification of the Agreement under Article 21.3(b) of the DSU Corrigendum This is to inform you that the reasonable pe riod of time in this dispute will expire on
Date: 6 July 2009
Document codes: WT/DS292/39/Corr.1; WT/DS292/39.
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Modification of the Agreement under Article 21.3(b) of the DSU

Corrigendum

 This is to inform you that the reasonable pe riod of time in this dispute will expire on
31 July 2009, and not 31 December 2009, as stated in document

COMMUNAUTÉS EUROPÉENNES - MESURES AFFECTANT
DES PRODUITS BIOTECHNOLOGIQUES

Modification de l'Accord au titre de l'article 21:3 b) du Mémorandum

Corrigendum

A LA APROBACIÓN Y COMERCIALIZACIÓN DE
PRODUCTOS BIOTECNOLÓGICOS

Corrigendum
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS292/15; WT/DS293/15; WT/DS292/1; WT/DS293/1
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of the United States and to the Chairman of the
Dispute Settlement Body is circulated at the request of the European Communities.
Thank you for your letters dated 28 May 2003 expressing the desire of the United States to be
joined in the consultations requested by Canada and Argentina on the approval and marketing of
genetically-modified organisms (documents and ).
The European Communities accepts the request of the United States. The consultations in the
disputes WT/DS291 and WT/DS293 will be held jointly, as agreed. I will inform you as soon as
possible of the date and venue of the consultations between the European Communities and Canada.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Reports of the Panel Addendum
Date: 29 September 2006
Document codes: WT/DS291/R/Add.4; WT/DS292/R/Add.4; WT/DS293/R/Add.4; WT/DS291/R; WT/DS292/R; WT/DS293/R.
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING
THE APPROVAL AND MARKETING
OF BIOTECH PRODUCTS

Reports of the Panel

Addendum

 This addendum contains Annex F to the Repor ts of the Panel to be found in document
, , The other annexes can be found in the following
addenda:

 – Annex C: Add.1
 – Annex D: Add.2
 – Annex E: Add.3
 – Annex G: Add.5
 – Annex H: Add.6
 – Annex I : Add.7
 – Annex J: Add.8
 – Annex K: Add.9
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from Mexico
Date: 5 June 2003
Document codes: WT/DS293/2
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from Mexico
The following communication, dated 27 May 2003, from the Permanent Mission of Mexico to
the Permanent Delegation of the European Commission, the Permanent Mission of Argentina and to
the Chairman of the Dispute Settlement Body, is circulated in accordance with Article 4.11 of the
DSU.
Pursuant to Article 4.11 of the Understanding on Rules and Procedures Governing the
Settlement of Disputes (DSU), I hereby notify Mexico's substantial trade interest and its desire to be
joined in the consultations requested by Argentina concerning the moratorium on the approval of
biotech products and the various marketing and import bans on biotech products maintained by
several EC members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from the United States
Date: 10 June 2003
Document codes: WT/DS293/3; WT/DS293/1
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from the United States
The following communication, dated 28 May 2003, from the Permanent Mission of the
United States to the Permanent Delegation of the European Commission, the Permanent Mission of
Argentina and to the Chairman of the Dispute Settlement Body, is circulated in accordance with
Article 4.11 of the DSU.
This concerns the request for consultations by Argentina in , circulated on 21 May 2003
(). My authorities have instructed me to notify the consulting Members and the Dispute
Settlement Body of the desire of the United States to be joined in these consultations, pursuant to
Article 4.11 of the Understanding on Rules and Procedures Governing the Settlement of Disputes.
The United States has a substantial trade interest in these consultations. The consultations
concern (1) the EC’s suspension of granting of new approvals for biotech products and (2) EC
member State import and marketing bans for certain EC-approved biotech products. The
United States has requested its own consultations concerning these matters (). This
suspension of new approvals and these member State import and marketing bans restrict substantial
imports of agricultural and food products from the United States.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from Australia
Date: 10 June 2003
Document codes: WT/DS293/4
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from Australia
The following communication, dated 28 May 2003, from the Permanent Mission of Australia
to the Permanent Delegation of the European Commission, the Permanent Mission of Argentina and
to the Chairman of the Dispute Settlement Body, is circulated in accordance with Article 4.11 of the
DSU.
In conformity with paragraph 11 of Article 4 of the Understanding on Rules and Procedures
Governing the Settlement of Disputes (DSU), I hereby notify Australia’s desire to be joined in the
consultations requested by Argentina on 14 May 2003 pursuant to Article 4 of the DSU , Article 11.1
of the Agreement on Sanitary and Phytosanitary Measures, Article 19 of the Agreement on
Agriculture, Article 14.1 of the Agreement on Technical Barriers to Trade and Article XXII.1 of the
General Agreement on Tariffs and Trade 1994 with regard to certain measures taken by the European
Communities and its member States which affect products of biotechnology. The request for
consultations by Argentina was circulated to Members on 21 May 2003 (, ,
, and refer).
Australia is a significant producer and exporter of agricultural products. As such, Australia
has a substantial trade interest in the consultations requested by Argentina.
We look forward to the European Communities’ confirmation of receipt and acceptance of
this request to join the consultations and advice regarding the timing and venue for the consultations.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from Brazil
Date: 12 June 2003
Document codes: WT/DS293/5
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from Brazil
The following communication, dated 28 May 2003, from the Permanent Mission of Brazil to
the Permanent Delegation of the European Commission, the Permanent Mission of Argentina and to
the Chairman of the Dispute Settlement Body, is circulated in accordance with Article 4.11 of the
DSU.
I refer to the requests for consultations by the United States, Canada, and Argentina with
regard to certain measures taken by the European Communities and its member States affecting
products of biotechnology (biotech products), made on 13 and 14 May 2003, pursuant to Article 4 of
the Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU), Article 11
of the Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement),
Article 19 of the Agreement on Agriculture , Article 14 of the Agreement on Technical Barriers to
Trade (TBT Agreement) and Article XXII of the General Agreement on Tariffs and Trade 1994
(GATT 1994), which were circulated to Members on 20 and 21 May 2003 (respectively,
, , EN/397, , 28; , ,
, , ; and , , ,

Brazil has substantial trade interests in the matter, as one of the largest world exporters of
agricultural commodities and one of the countries of greatest biodiversity in the world, among other
reasons. I therefore wish to convey the desire of the Government of Brazil, pursuant to Article 4.11 of
the DSU, to join in those consultations.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request to Join Consultations Communication from Canada
Date: 12 June 2003
Document codes: WT/DS293/6
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Request to Join Consultations
Communication from Canada
The following communication, dated 30 May 2003, from the Permanent Mission of Canada to
the Permanent Delegation of the European Commission, the Permanent Mission of Argentina and to
the Chairman of the Dispute Settlement Body, is circulated in accordance with Article 4.11 of the
DSU.
Pursuant to Article 4.11 of the Understanding on Rules and Procedures Governing the
Settlement of Disputes (DSU), the Government of Canada hereby notifies its desire to be joined in
consultations requested by Argentina pursuant to Article 4 of the Understanding on Rules and
Procedures Governing the Settlement of Disputes (DSU), Article 11.1 of the Agreement on the
Application of Sanitary and Phytosanitary Measures , Article 19 of the Agreement on Agriculture ,
Article 14.1 of the Agreement on Technical Barriers to Trade (TBT Agreement), and Article XXII:1
of the General Agreement on Tariffs and Trade 1994 , with respect to certain measures taken by the
European Communities (EC) and its Member States affecting products of biotechnology (biotech
products). The relevant communication from the Permanent Mission of Argentina to the Permanent
Mission of the European Communities, dated 14 May 2003, was circulated to WTO Members on
21 May 2003.
Canada has both a substantial and systemic interest in the issues under consultation. Canada is
one of the world’s largest producers of biotech products. In particular, it grows and exports several
canola (rapeseed) and corn biotech varieties that are the subject of applications for approval in the
EC’s regulatory approvals regime, or that have been approved but are banned in individual EC
Member States. As a consequence, Canada has a substantial trade interest in these consultations.
Moreover, Canada has a significant systemic interest in the proper interpretation of WTO disciplines
applicable to biotech product approvals regimes, as cited by Argentina in its request for consultations.